Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline (Q43195244)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 January 2010
edit
Language Label Description Also known as
English
Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline
scientific article published on 13 January 2010

    Statements

    Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit